alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EX-10.2



 Exhibit 10.2 
 AMENDMENT NO. 6 TO THE 
 AIR PRODUCTS AND CHEMICALS, INC. 

RETIREMENT SAVINGS PLAN 
 WHEREAS, Air Products and Chemicals, Inc. (the “Company”) is the Plan Sponsor of the Air Products and Chemicals, Inc. Retirement Savings Plan (the “Plan”); and 

WHEREAS, pursuant to Plan Section 7.01 the Plan may be amended at anytime; and 

WHEREAS, the Company desires to amend the Plan to update Exhibit I to include three new eligible hourly locations. 

NOW, THEREFORE, the Plan is hereby amended as follows: 

 

	 	1.	Exhibit I is amended as attached hereto to include three new locations effective as of the following dates: 


Memphis, TN – February 1, 2012 
 Bozrah, CT – February 13, 2012 
 Butler, PA – July 2, 2012

  

	 	2.	In all other respects the Plan shall remain in full force and effect. 

 IN WITNESS WHEREOF, the Company has caused its Senior Vice President, General Counsel and Chief Administrative Officer to execute this Sixth Amendment to the Plan on this
             day of May 2013. 
  

			
	AIR PRODUCTS AND CHEMICALS, INC.
		
	By:	 	  

		 	Senior Vice President, General Counsel and
		 	Chief Administrative Officer










 Exhibit 10.2 

 

 EXHIBIT I 
 ELIGIBLE NONUNION HOURLY LOCATIONS DESIGNATED 
 BY VICE PRESIDENT - HUMAN
RESOURCES 
 EFFECTIVE AS OF July 2, 2012: 

 

			
	 	  	 Designated Terminal

	 	  	 For 125% of Base Salary

		
	ASHLAND, KY	  	YES
	BETHLEHEM, PA	  	YES
	BOUNTIFUL, UT	  	YES
	BOZRAH, CT	  	YES
	BURNS HARBOR, IN	  	NO
	BUTLER, IN	  	YES
	BUTLER, PA	  	YES
	CAMDEN, SC	  	YES
	 CARTERSVILLE, GA
 CHANDLER,
AZ
	  	 YES
 YES

	CONVENT, LA	  	NO
	CONVENT, LA (Drivers)	  	YES
	CONYERS, GA	  	YES
	CREIGHTON, PA	  	YES
	DECATUR, AL	  	YES
	DEER PARK, TX	  	NO
	EAGAN, MN	  	YES
	GLENMONT, NY	  	YES
	GRAY, TN	  	YES
	LANCASTER, PA	  	YES
	LANCASTER, PA (Express Services)	  	NO
	LAPORTE, TX	  	YES
	LASALLE, IL	  	YES
	LIBERAL, KS	  	YES
	 LONG BEACH, CA
 MANALAPAN,
NJ
	  	 YES
 NO

	 MCINTOSH, AL
 MEMPHIS,
TN
	  	 YES
 YES

	MIDLOTHIAN, TX	  	YES
	MOORELAND, OK	  	YES
	NEW MARTINSVILLE, WV	  	YES
	NIAGARA FALLS, NY	  	YES
	OAK CREEK, WI	  	YES
	ORLANDO, FL	  	YES
	PACE, FL	  	YES









			
	PARKERSBURG, WV	  	YES
	PRYOR, OK	  	YES
	PUYALLUP, WA	  	YES
	REIDSVILLE, NC	  	YES
	SHAKOPEE, MN	  	YES
	SMITHVILLE, MO	  	YES
	SPARROWS POINT, MD (Drivers)	  	YES
	SUFFIELD, CT	  	YES
Exhibit 99.1



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of Apogent Technologies Inc. (the Company) on Form 10-Q
for the period ended March 31, 2003 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Frank H. Jellinek, Jr., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as
adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:



| | (1) |  | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- |  | ---------------------------------------------------------------------------------------------------------------------



| | (2) |  | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------



/s/ FRANK H. JELLINEK, JR.Frank H. Jellinek, Jr. Chief Executive Officer  May 13, 2003




This certification
accompanies this Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. A signed original of this written statement
required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 180 Introduced in House (IH)]

<DOC>

116th CONGRESS
  1st Session
H. RES. 180

Supporting the designation of March 2019 as National Colorectal Cancer 
                            Awareness Month.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             March 6, 2019

Mr. Payne (for himself, Mr. Raskin, Ms. Norton, Mr. Panetta, Mr. Soto, 
Mr. Johnson of Georgia, Mr. Fitzpatrick, Ms. Jackson Lee, Ms. Clarke of 
  New York, Mr. Cohen, Ms. Slotkin, Mr. Blumenauer, Mr. McEachin, Mr. 
  Rodney Davis of Illinois, Mr. Rush, and Mr. Hastings) submitted the 
following resolution; which was referred to the Committee on Oversight 
                               and Reform

_______________________________________________________________________

                               RESOLUTION

 
Supporting the designation of March 2019 as National Colorectal Cancer 
                            Awareness Month.

Whereas colorectal cancer is the second leading cause of cancer death among men 
        and women combined in the United States;
Whereas in 2019, more than 145,600 Americans will be diagnosed with colorectal 
        cancer and approximately 51,000 Americans will die from it;
Whereas colorectal cancer is one of the most highly preventable forms of cancer 
        because screening tests can find polyps that can be removed before 
        becoming cancerous;
Whereas screening tests can detect colorectal cancer early, when treatment works 
        best;
Whereas the Centers for Disease Control and Prevention estimates that if every 
        individual aged 50 or older had regular screening tests, as many as 60 
        percent of deaths from colorectal cancer could be prevented;
Whereas the 5-year survival rate for patients with localized colorectal cancer 
        is 90 percent, but only 39 percent of all diagnoses occur at this stage;
Whereas colorectal cancer screenings can effectively reduce colorectal cancer 
        incidence and mortality, yet, 1 in 3 adults over 50 years of age are not 
        up to date with recommended colorectal cancer screening;
Whereas public awareness and education campaigns on colorectal cancer 
        prevention, screening, and symptoms are held during the month of March 
        each year; and
Whereas educational efforts can help provide information to the public of 
        methods of prevention and screening, as well as about symptoms for early 
        detection: Now, therefore, be it
    Resolved, That the House of Representatives--
            (1) supports the goals and ideals of National Colorectal 
        Cancer Awareness Month; and
            (2) encourages the people of the United States to observe 
        the month with appropriate awareness and educational 
        activities.
                                 <all>
```
EX-10.3


 Exhibit 10.3 

 
 



 
 6528 Kaiser Drive 
 Fremont, CA 
 (510) 896-3015 (ph) 

(510) 896-3010 (fax) 
 July 22, 2013 
 Sean Suresh Narayanan 

No.132 B (Old No.57/1) ECC Road, 
 Whitefield,

 Bangalore – 560 066 
 India

 Dear Sean: 
 On July 17, 2013,
the Compensation Committee (the “Committee”) of the Board of Directors of iGATE Corporation (the “Company”) approved a retention bonus plan (the “Retention Bonus Plan”), in order to ensure that the key members of the
Company’s management team remain with the Company and stay focused on growing the Company’s business. This letter (the “Retention Bonus Agreement”) sets forth the terms of your eligibility for and the amount of this additional
incentive. This Retention Bonus Agreement is supplemental to, and does not impact, other compensation you are entitled to as an employee of the Company. 
 The Retention Bonus Plan provides for the payment of a Retention Bonus (the “Retention Bonus”) to you in the amount of $150,000 on June 30, 2014 and $100,000 on December 31, 2014. In
order to be eligible for each payment, you must be an employee on the applicable date of payment: June 30, 2014 and December 31, 2014 (the “Payment Dates”). 
 You will not be eligible for, and will not receive any portion of, the Retention Bonus if you resign for any reason prior to the Payment Dates or if the Company terminates your employment for any reason
prior to the Payment Dates. The Retention Bonus will be subject to applicable deductions and withholdings and will not be considered compensation for purposes of any other compensation or benefit program sponsored or maintained by the Company.

 This Retention Bonus Agreement sets forth the entire understanding between you and the Company with regard to the Retention Bonus and any
retention or “stay” bonus and may not be modified except by written agreement executed by you and a duly authorized representative of the Company, as determined by the Committee. 
 We thank you for your many contributions to the Company and your ongoing support during this transition. Please sign below and return an executed copy of this Retention Agreement to me by July 22,
2013 in order to indicate your understanding and acceptance of these terms. 

  
 Page 1 of 2








 Please sign below as your acceptance of these terms. We greatly appreciate your past hard work and efforts
on behalf of the Company and look forward to continuing to work with you under the terms of this Agreement. 
  

			
	Very truly yours,
		
	By:	 	/s/ Gerhard Watzinger        
		 	Gerhard Watzinger
		 	 Chief Executive Officer
 and
President


  

			
	Agreed to by:
		
		 	/s/ Sean Suresh Narayanan            7/22/13
		 	Sean Suresh Narayanan                 Date


  
 Page 2 of 2
EX-10.13



 Exhibit 10.13 
 CONFIDENTIAL 
 Amendment No. 1 to the Executive Severance Benefits
Agreement 
 This Amendment No. 1 to the Executive Severance Benefits Agreement (this “Amendment”),
effective December 5, 2012 (the “Amendment Effective Date”), is made and entered into by and between Five Prime Therapeutics, Inc., a Delaware corporation (“FivePrime”), and Aron Knickerbocker, an individual
(“Executive”). 
 Background 
 A.        FivePrime and Executive are parties to the Executive Severance Benefits Agreement, dated December 30, 2009 (the “Agreement”).

 B.        FivePrime and Executive desire to amend the Agreement, in accordance
with Section 7.7 of the Agreement. 
 NOW, THEREFORE, FivePrime and Executive agree as follows: 

1.        Amendment of the Agreement. FivePrime and Executive agree to amend the terms of the
Agreement as provided below, effective as of the Amendment Effective Date. Where the Agreement is not explicitly amended, the terms of the Agreement will remain in full force and effect. Capitalized terms used in this Amendment that are not
otherwise defined herein shall have the same meanings as such terms are given in the Agreement. 

2.        Title of Executive. Section 1.1 of the Agreement is hereby amended and restated in
its entirety as set forth below: 
 “The Company desires to employ Executive, or to continue Executive’s employment,
in the position of Senior Vice President and Chief Business Officer, and Executive wishes to be employed, or continue to be employed, by the Company in such position.” 
 3.        Change in Control Severance Period. Section 6.5 of the Agreement is hereby amended and restated in its entirety as set forth below:

 ““Change in Control Severance Period” means the period of eighteen (18) months commencing on the
Termination Date.” 
 4.        Covered Termination Severance Period.
Section 6.11 of the Agreement is hereby amended and restated in its entirety as set forth below: 

““Covered Termination Severance Period” means the period of nine (9) months commencing on the
Termination Date.” 
 5.        Miscellaneous. 

5.1        Full Force and Effect. This Amendment amends the terms of the Agreement
and is deemed incorporated into the Agreement. The provisions of the Agreement, as amended by this Amendment, remain in full force and effect. 

  
 1 









 CONFIDENTIAL 

 

 5.2        Entire Agreement. The
Agreement, as amended by this Amendment, sets forth the entire understanding of FivePrime and Executive relating to the subject matter thereof and supersedes all prior agreements and understandings between FivePrime and Executive relating to the
subject matter thereof. 
 IN WITNESS WHEREOF, FivePrime and Executive have executed this Amendment as of the Amendment
Effective Date. 
 Five Prime Therapeutics, Inc. 
  

					
	 /s/ Lewis T. Williams
	 		  	/s/ Aron Knickerbocker
	 Lewis T. Williams

President and Chief Executive Officer
	 		  	Aron Knickerbocker


  
 2
97-283.

#### State ex rel. Woods v. Niehaus.

In Procedendo. On motion to dismiss. Motion to dismiss sustained. Cause dismissed.

Moyer, C.J., Douglas, Resnick, F.E. Sweeney, Pfeifer, Cook and Lundberg Stratton, JJ., concur.
<TABLE> <S> <C>

<ARTICLE> UT
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          SEP-30-1996
<PERIOD-START>                             OCT-01-1995
<PERIOD-END>                               SEP-30-1996
<BOOK-VALUE>                                  PER-BOOK
<TOTAL-NET-UTILITY-PLANT>                      493,564
<OTHER-PROPERTY-AND-INVEST>                      9,251
<TOTAL-CURRENT-ASSETS>                          93,640
<TOTAL-DEFERRED-CHARGES>                        33,767
<OTHER-ASSETS>                                  54,031
<TOTAL-ASSETS>                                 684,253
<COMMON>                                        44,761
<CAPITAL-SURPLUS-PAID-IN>                      101,784
<RETAINED-EARNINGS>                             81,441
<TOTAL-COMMON-STOCKHOLDERS-EQ>                 227,986
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                      5,009
<LONG-TERM-DEBT-NET>                           196,500
<SHORT-TERM-NOTES>                              64,650
<LONG-TERM-NOTES-PAYABLE>                      196,500
<COMMERCIAL-PAPER-OBLIGATIONS>                  18,000
<LONG-TERM-DEBT-CURRENT-PORT>                   18,000
<PREFERRED-STOCK-CURRENT>                            0
<CAPITAL-LEASE-OBLIGATIONS>                        694
<LEASES-CURRENT>                                   917
<OTHER-ITEMS-CAPITAL-AND-LIAB>                 171,414
<TOT-CAPITALIZATION-AND-LIAB>                  684,253
<GROSS-OPERATING-REVENUE>                      428,784
<INCOME-TAX-EXPENSE>                            16,953
<OTHER-OPERATING-EXPENSES>                     372,539
<TOTAL-OPERATING-EXPENSES>                     389,492
<OPERATING-INCOME-LOSS>                         39,292
<OTHER-INCOME-NET>                               3,843
<INCOME-BEFORE-INTEREST-EXPEN>                  43,135
<TOTAL-INTEREST-EXPENSE>                        16,063
<NET-INCOME>                                    27,072
<PREFERRED-STOCK-DIVIDENDS>                        293
<EARNINGS-AVAILABLE-FOR-COMM>                   26,779
<COMMON-STOCK-DIVIDENDS>                        20,361
<TOTAL-INTEREST-ON-BONDS>                          694
<CASH-FLOW-OPERATIONS>                           7,138
<EPS-PRIMARY>                                     2.00
<EPS-DILUTED>                                     1.98
        

</TABLE>
EXHIBIT 32(a)



Certification



Pursuant to 18 U.S.C. Section 1350, the undersigned officer of The Bank of New York Company, Inc. (the Company) hereby certifies that the
Companys Annual Report on Form 10-K for the year ended December 31, 2005 (the Report) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that the
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Dated: February 28, 2006



/s/ Thomas A. RenyiName:

Thomas A. RenyiTitle:

Chief Executive Officer




The foregoing
certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of the Report or as a separate disclosure document.
----

** Exhibit 31.2**

**  CERTIFICATIONS**

I, Martin S. Smiley, certify that:

1.

I have reviewed this quarterly report on Form 10-Q of mPhase Technologies, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant's and have:

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

c.

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.

The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

/s/ Martin S. Smiley               

Martin S. SmileyChief Financial Officer

November 14, 2008

----
<TABLE> <S> <C>

<ARTICLE>                           5
<CIK>                               0000850506
<NAME>                              GEODYNE ENERGY INCOME LTD PSHIP II-F

<S>                                 <C>
<PERIOD-TYPE>                       9-MOS
<FISCAL-YEAR-END>                   DEC-31-1999
<PERIOD-START>                      JAN-01-1999
<PERIOD-END>                        SEP-30-1999
<CASH>                                    243,149
<SECURITIES>                                    0
<RECEIVABLES>                             301,367
<ALLOWANCES>                                    0
<INVENTORY>                                     0
<CURRENT-ASSETS>                          544,516
<PP&E>                                 11,104,484
<DEPRECIATION>                          9,274,342
<TOTAL-ASSETS>                          2,421,031
<CURRENT-LIABILITIES>                      26,145
<BONDS>                                         0
<PREFERRED-MANDATORY>                           0
<PREFERRED>                                     0
<COMMON>                                        0
<OTHER-SE>                              2,369,891
<TOTAL-LIABILITY-AND-EQUITY>            2,421,031
<SALES>                                 1,225,529
<TOTAL-REVENUES>                        1,231,857
<CGS>                                           0
<TOTAL-COSTS>                             756,522
<OTHER-EXPENSES>                                0
<LOSS-PROVISION>                                0
<INTEREST-EXPENSE>                              0
<INCOME-PRETAX>                           475,335
<INCOME-TAX>                                    0
<INCOME-CONTINUING>                       475,335
<DISCONTINUED>                                  0
<EXTRAORDINARY>                                 0
<CHANGES>                                       0
<NET-INCOME>                              475,335
<EPS-BASIC>                                2.36
<EPS-DILUTED>                                   0



</TABLE>
IV 

116TH CONGRESS 

1ST SESSION H. RES. 178 

Directing the Fine Arts Board to accept the gift of a portrait of Alice 

Paul for placement in the House of Representatives wing of the United 

States Capitol or an office building of the House, and directing the 

Architect of the Capitol to place the portrait in a suitable permanent 

location. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 5, 2019 

Mr. NORCROSS submitted the following resolution; which was referred to the 

Committee on House Administration 

RESOLUTION 

Directing the Fine Arts Board to accept the gift of a portrait 

of Alice Paul for placement in the House of Representatives wing of the United States Capitol or an office 

building of the House, and directing the Architect of 

the Capitol to place the portrait in a suitable permanent 

location. 

Whereas Alice Paul was a leader in the women’s suffrage 

movement in the United States, worked for two years 

with the National American Woman Suffrage Association, cofounded the Congressional Union seeking a Federal constitutional amendment for women’s suffrage, and 

in 1916, formed the National Woman’s Party; 


pamtmann on DSKBFK8HB2PROD with BILLS
2 

•HRES 178 IH 

Whereas, in 1920, Alice Paul was instrumental in the passage and ratification of the 19th Amendment, which prohibited denying any citizen the right to vote on the basis 

of sex; 

Whereas, in 1923, Alice Paul penned the Equal Rights 

Amendment, which was introduced in every congressional 

term between 1923 and 1972; 

Whereas Alice Paul continued to advocate on behalf of 

women until her death on July 9, 1977; and 

Whereas Alice Paul was a driving force behind the attainment of women’s suffrage and the national movement toward equality for women: Now, therefore, be it 

1 Resolved, That the House of Representatives— 

2 (1) directs the Fine Arts Board to accept the 

3 gift of a portrait of Alice Paul for placement in the 

4 House of Representatives wing of the United States 

5 Capitol or an office building of the House; and 

6 (2) directs the Architect of the Capitol to place 

7 the portrait in a suitable permanent location. 

Æ 


pamtmann on DSKBFK8HB2PROD with BILLS
<PAGE>

                                                                    EXHIBIT 23.2

INDEPENDENT AUDITORS' CONSENT

We consent to the incorporation by reference in the Post-Effective Amendment to
Registration Statement No. 33-13901, and in Registration Statement Nos.
33-73696, 33-73698, 33-73700, 333-17349, 333-17351, 333-50356, 333-75388,
333-75390, 333-102070 and 333-102072 of Barr Laboratories, Inc. on Form S-8 of
our report dated November 30, 2001, with respect to the consolidated financial
statements of Duramed Pharmaceuticals, Inc. included in this Annual Report on
Form 10-K of Barr Laboratories, Inc. for the year ended June 30, 2003.

                                    /s/ Ernst & Young LLP

Cincinnati, Ohio
August 26, 2003